Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
INMD · against 588 other Healthcare companies listed in US-listed
Ranked #2 of 589 · scores higher than 98% of peers
Bars: peers in each 10-point band of the valuation score28 peers with a valuation score of 90–100, including INMD · Click a bar to see the companies
Mainly thanks to its EBITDA yield, free cash flow yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | INMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 8.6% | -4.3% | 95% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 21.2% | -0.8% | 95% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 10.2% | -2.3% | 95% | 20% | |
| Book yieldHigher is better · 587 reported | 75.9% | 25.9% | 86% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 2 | 578M USD | 96 | 73 | |
| 2 | 2.1B USD | 96 | 96 | |
| 2 | 1.2B USD | 96 | 75 | |
| 2 | 10.4B USD | 96 | 64 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score